Clinical Trials: Pradaxa (dabigatran etexilate) and Stroke Prevention

From today's Guardian:

Major drug trial highlights a new approach in stroke prevention
The success of Pradaxa in a 44-country trial indicates a possible end to the use of the rat poison warfarin as a primary treatment to prevent stroke
Press Association
guardian.co.uk
Sunday 30 August 2009 23.27 BST

Read the full article

Boehringer Ingelheim's (BI) corporate website information about their clinical trial programmes: click here